ATE424834T1 - Zellulosesulfat zur behandlung von rhinovirus- infektionen - Google Patents

Zellulosesulfat zur behandlung von rhinovirus- infektionen

Info

Publication number
ATE424834T1
ATE424834T1 AT06450052T AT06450052T ATE424834T1 AT E424834 T1 ATE424834 T1 AT E424834T1 AT 06450052 T AT06450052 T AT 06450052T AT 06450052 T AT06450052 T AT 06450052T AT E424834 T1 ATE424834 T1 AT E424834T1
Authority
AT
Austria
Prior art keywords
treatment
cellulose sulfate
rhinovirus infections
rhinovirus
polymer
Prior art date
Application number
AT06450052T
Other languages
English (en)
Inventor
Andreas Grassauer
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Application granted granted Critical
Publication of ATE424834T1 publication Critical patent/ATE424834T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06450052T 2006-04-04 2006-04-04 Zellulosesulfat zur behandlung von rhinovirus- infektionen ATE424834T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06450052A EP1842546B1 (de) 2006-04-04 2006-04-04 Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen

Publications (1)

Publication Number Publication Date
ATE424834T1 true ATE424834T1 (de) 2009-03-15

Family

ID=36844837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06450052T ATE424834T1 (de) 2006-04-04 2006-04-04 Zellulosesulfat zur behandlung von rhinovirus- infektionen

Country Status (3)

Country Link
EP (1) EP1842546B1 (de)
AT (1) ATE424834T1 (de)
DE (1) DE602006005612D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014147287A1 (en) * 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
AU2001268884A1 (en) * 2000-06-30 2002-01-14 Polydex Pharmaceuticals Limited Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
WO2005004882A1 (en) * 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Also Published As

Publication number Publication date
EP1842546B1 (de) 2009-03-11
EP1842546A1 (de) 2007-10-10
DE602006005612D1 (de) 2009-04-23

Similar Documents

Publication Publication Date Title
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA200802213A1 (ru) Способы лечения заболеваний крови
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
ECSP077360A (es) Compuestos sulfonamida
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
CL2008002384A1 (es) Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
EA200900261A1 (ru) Применение эсцина
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ATE501717T1 (de) Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE424834T1 (de) Zellulosesulfat zur behandlung von rhinovirus- infektionen
ATE533496T1 (de) Azithromycin zur behandlung von knotiger akne
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
ATE456949T1 (de) Verwendung von bupropionmetaboliten zur behandlung von entzündungserkrankungen
EA200870263A1 (ru) Внутривенный способ лечения вирусной инфекции
ATE429910T1 (de) Chlor enthaltende guanabenz derivate zur behandlung von prionerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties